Prabhudas Lilladher recommended accumulate rating on Ipca Laboratories with a target price of Rs 1525 in its research report dated August 13, 2025.
Prabhudas Lilladher recommended accumulate rating on Ipca Laboratories with a target price of Rs 1525 in its research report dated May 31, 2025.
Stocks to watch, 30 May: Stocks like Procter and Gamble Health, Amara Raja Energy & Mobility, Gujarat Pipavav Port, ICRA, SJVN, NLC India, Harsha Engineers International, IFB Agro Industries, InterGlobe Aviation, Bajaj Auto, Ipca Laboratories,Mazagon Dock Shipbuilders,Lemon Tree Hotels, and Suzlon Energy will be in focus on May 30.
Kaygee Investments (KIPL) had sort clarification over a merger with another promoter entity PCPL
The rebound after a severe fall can't be ruled out, but the sustainability is key to watch. Below are some trading ideas for the near term.
Prabhudas Lilladher recommended accumulate rating on Ipca Laboratories with a target price of Rs 1700 in its research report dated February 14, 2025.
Motilal Oswal is bullish on IPCA Laboratories recommended buy rating on the stock with a target price of Rs 1980 in its research report dated December 27, 2024.
The market is expected to remain rangebound with a positive bias in the upcoming sessions. Below are some trading ideas for the near term.
The chart structure of Nifty 50 is indicating sideways to bearish momentum for the next couple of weeks.
Stocks like Ipca Laboratories, Gujarat Toolroom, Cummins India, Asian Paints, Vardhman Polytex, ITC, State Bank of India, JSW Infrastructure, Allcargo Gati, IOL Chemicals, Brigade Enterprises, Wipro, Borosil Renewables, and IRCON International will also be in focus on December 19.
Sharekhan is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1765 in its research report dated November 14, 2024.
Prabhudas Lilladher recommended accumulate rating on Ipca Laboratories with a target price of Rs 1700 in its research report dated November 18, 2024.
Sharekhan is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1765 in its research report dated November 14, 2024.
Motilal Oswal is bullish on IPCA Laboratories recommended buy rating on the stock with a target price of Rs 1950 in its research report dated October 14, 2024.
Sharekhan is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1734 in its research report dated September 30, 2024.
Nomura bumped up its price target on IPCA Labs to Rs 1,750, seeing a 20 percent upside from the previous close.
Overall, the market trend is expected to remain positive despite occasional consolidation. Here are some trading ideas for the near term.
Motilal Oswal recommended Neutral rating on Ipca Laboratories with a target price of Rs 1310 in its research report dated August 14, 2024.